Biocracked
Approach: Macro science, the human outcome angle through tissue. Palette: D, bold color field.

Extreme close-up of a cross-section of raw beef thigh muscle, used as a stand-in for human thigh tissue. It is shot straight on and slightly from above, on a saturated tomato-red seamless backdrop. Fine white fat marbling threads run through the dark red muscle fibers. On one half the marbling is dense and lacy, and on the other it is sparse and clean, so the contrast reads as a before and after. A thin, translucent calipers-style steel ruler lies along the edge, with no markings readable. Lighting is soft, directional studio light from the upper left, with crisp highlights on the glistening fibers and gentle warm shadows. A single small electric green surgical marker dot sits on the tissue. The mood is analytical, tense and uncertain, with shallow depth of field and sharp detail on the fat texture.
Longevity

Semaglutide Dosis Tinggi lan Otot Paha: Apa sing Dituduhaké MRI

Helix Ward · · 4 min read

Few worries about GLP-1 drugs spread as quickly as the fear of losing muscle along with fat. A new MRI sub-analysis of the STEP UP trial, which tested semaglutide at 7.2 mg (well above the 2.4 mg Wegovy dose), offers a more nuanced picture than either the alarmists or the optimists would like. It is also a small study, and it needs careful reading.

Apa sing ditindakake studi

STEP UP iku uji fase 3b sing acakaké wong diwasa kanthi BMI 30 utawa luwih menyang semaglutide mingguan 7,2 mg, semaglutide 2,4 mg, utawa placebo sajrone 72 minggu, bareng intervensi gaya urip. Analisis sekunder sing wis diset sadurunge iki, diterbitaké ing Diabetes, Obesity and Metabolism lan dipimpin déning Jøran Hjelmesæth, nliti komposisi awak sing diukur MRI lan tes fungsi fisik.

Nang kéné ana jebakan: mung 55 saka 1.407 peserta uji coba sing nduwèni scan dasar sing sah lan kalebu ing analisis. Saka iku, 43 njupuk semaglutide 7,2 mg, 6 njupuk 2,4 mg, lan mung 6 nampa placebo. Para peneliti nggabungaké loro lengan semaglutide (n = 49) lan dibandhingaké karo placebo.

Temuan Pokok

  • Total adipose tissue: down 11.1 L (95% CI -16.5 to -5.7; p < 0.0001)
  • Visceral adipose tissue: down 1.5 L (p = 0.04)
  • Lean body tissue: down 1.7 L (95% CI -4.0 to 0.7; p = 0.16)
  • Thigh skeletal muscle volume: down 1.1 L (95% CI -2.3 to 0.1; p = 0.07)
  • Thigh muscle fat infiltration: down 0.92 percentage points (p = 0.001)

Analisis sensitivitas sing mung mbandhingaké grup 7,2 mg karo placebo ngasilaké asil sing padha. Perubahan relatif uga nuduhaké arah sing padha.

Penurunan lemak jelas, volume otot ora

Asil lemak kuwat, sanajan sampel cilik. Kehilangan kira‑kira 11 liter jaringan lemak dibanding placebo, kalebu penurunan lemak visceral sing terukur, iku sing diarep‑ake saka obat ing dosis iki.

Asil otot luwih angel dipahami. Owah‑owahan volume otot paha ora nggayuh signifikansi statistik, nanging nilai p = 0,07 lan interval kapercayan saka -2,3 L nganti +0,1 L ora dadi bukti ora ada kehilangan. Mung enam peserta placebo, studi iki ora cukup daya kanggo ndeteksi bedane. "Ora signifikan" ing kéné luwih ateges "kita ora bisa mangerteni". Kesimpulan penulis nyatakake semaglutide kagandheng karo penurunan jaringan lemak, volume otot rangka, lan infiltrasi lemak otot, mula ora ngaku yen otot tetep aman.

Ing liter mentah, perubahan otot paha kira‑kira saperser puluh saka perubahan lemak. Perbandingan iki kudu diperlakukan longgar, amarga jaringan lan kompartemen beda, nanging cocok karo apa sing diusulake studi komposisi awak gedhé babagan obat penurunan bobot: mayoritas massa sing ilang iku lemak, karo sebagian cilik sing saka jaringan tanpa lemak. Jaringan tanpa lemak uga kalebu banyu, organ, lan komponen non‑otot liyane, mula penurunan massa tanpa lemak ora otomatis artine penurunan otot.

Sinyal Kualitas Otot

Asil sing luwih menarik yaiku penurunan infiltrasi lemak ing otot paha. Lemak sing nyebar ing antarane serat otot gegandhengan karo kekuatan lan kesehatan metabolik sing luwih ala, lan cenderung nglumpuk nalika obesitas, resistensi insulin, lan penuaan. Penurunan 0,92 poin persen nuduhaké otot sing tetep ana dadi luwih “resik”.

Nanging atur antusiasmu. Perubahan absoluté cilik, lan studi iki ora nuduhaké manawa iki dadi peningkatan kekuatan, mobilitas, utawa hasil jangka panjang. Infiltrasi lemak mung minangka penanda proksi, dudu asil fungsional.

Fungsi Fisik: Nyenengake nanging Terbatas

Ukuran fungsi iki tes duduk‑ngadeg 30 detik. Abstrak nyatakake rata‑rata kira‑kira 13 ulangan ing baseline lan 15 ing minggu ke‑72 ing kelompok gabungan semaglutide lan placebo. Fungsi ora mudhun, sing nyenengake. Nanging tes iki kasar, dilakokaké ing subset cilik, lan abstrak ora nyedhiyakake perbandingan bersih antara perlakuan lan placebo. Iki ora dadi pangganti tes kekuatan kaya grip strength utawa leg press.

Cathetan Penting

  • Kelompok perbandingan cilik: Enem peserta placebo ndadékaké saben perkiraan antar‑kelompok dadi rapuh.
  • Seleksi subset: Peserta sing nduwèni scan MRI baseline sing sah bisa uga ora makili populasi uji coba sacara keseluruhan.
  • Keterlibatan industri: Uji coba iki digawé déning Novo Nordisk, lan sawetara panulis yaiku karyawan utawa pemegang saham Novo Nordisk. Analisis MRI melibataké AMRA Medical, sing penulisé uga ngakoni hubungan karo industri. Iki ora mbatalaké data, nanging kudu dadi konteks sing dipertimbangaké déning pamaca.
  • Analisis sekunder: Temuan iki ngasilaké hipotesis, ora final.
  • Komponen gaya urip: Peserta nampa intervensi gaya urip, dadi asil iki bisa uga ora cocok kanggo wong sing mung nganggo obat tanpa dukungan.

Para penulis dhewe nyuwun riset luwih lanjut babagan kepiye penurunan bobot mengaruhi komposisi lan fungsi otot.

Poin Praktis Kanggo Wong sing Nggunakake GLP-1

Studi iki ora bisa maringi cara nglindhungi otot, amarga ora nyoba strategi apa wae kanggo njaga otot. Nanging, iki ngukuhaké pendekatan wicaksana adhedhasar bukti luwih luas babagan penurunan bobot lan penuaan:

  1. Angkat beban. Latihan resistensi loro nganti telu kali seminggu iku sinyal paling dipercaya supaya awakmu njaga otot nalika defisit kalori.
  2. Prioritasake protein. Nafsu makan sing mudhun bisa kanthi alus nyuda asupan protein. Akeh dokter nyaranake kira‑kira 1,2 nganti 1,6 g protein per kg bobot awak saben dina, disesuaikan karo kesehatan ginjal lan kabutuhan individu. Konsultasi karo tim perawatanmu.
  3. Aja mung ngandelake timbangan. Cathet lingkar pinggul, kekuatan, lan kepenakane nglakoni kegiatan saben dina. Yen bisa, gunakake uga ukuran komposisi awak.
  4. Ati‑ati yen sampeyan luwih tuwa utawa wis lemes. Wong sing berisiko sarcopenia duwe margin sing luwih sithik kanggo kehilangan otot lan bisa entuk manfaat saka pemantauan sing luwih ketat.
  5. Takon babagan dosis lan laju. Penurunan bobot sing luwih cepet lan gedhé tegese total jaringan sing ilang luwih akèh, dadi strategi perlindungan dadi luwih penting.

Kesimpulan

Analisis MRI cilik iki nuduhaké manawa semaglutide dosis tinggi paling akeh ngilangi lemak, kalebu lemak visceral, nalika infiltrasi lemak otot paha nambah lan fungsi fisik dhasar tetep stabil. Iki ora mbuktekaké yen otot aman. Estimasi volume otot paha cenderung mudhun, lan sampel cilik banget kanggo netepaké jawaban. Kanggo sapa wae sing nggunakake obat GLP-1, pesené ora kudu panik babagan otot, nanging uga ora kudu diabaikan. Penurunan lemak bisa dadi bonus, lan otot sing sampeyan jaga kudu dilatih lan diparingi nutrisi.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

HW

Written by

Helix Ward

Helix Ward writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Ora Ngerusak Sel Otot Manungsa, Dadi Kok Otot Kethil?

BY DR. SYNAPSE ·

Apa semaglutide bener‑bener nyerang otot? Panaliten ing *GeroScience* ngaplikasikake semaglutide langsung marang sel otot primer manungsa sing wis tuwa lan kegemukan, lan sel‑sel mau ora kethil. Ora ana gen atrofik sing diaktifake, ora ana sinyal darurat sing ngganggu, malah GIP nambah kandel myotube sawise wolu dina. Semaglutide mung nyuda produksi ATP liwat glikolisis kanthi sithik, lan reseptor GLP‑1 mung sithik ditemokake. Asilé nuduhaké yèn mundhut massa otot luwih disebabake defisit kalori lan beban sing suda, dudu amarga semaglutide langsung ngrusak otot.

Approach: 3, the human outcome, here as an animal-science moment. Palette: C, natural.

An old female lab mouse with slightly greying, ruffled fur sits upright on a researcher's open gloved palm, photographed at eye level in a close side-on view with a shallow depth of field. Behind it, a softly blurred animal facility window pours in real morning daylight, giving the scene a pale green-grey and warm-wood setting. The nitrile glove is a vivid electric green (#00e676), the single saturated accent. The mouse's whiskers and pink ears catch the light, and the researcher's white coat sleeve is just visible. Tones are natural: skin, soft cream bedding, sage walls. The mood is calm, careful and quietly hopeful, and it conveys age and care rather than drama. The image has no text, no labels and no readable writing.
longevity

Bahan Aktif Ozempic Nambah Umur Tikus Tuwa: Kene Alasane

BY DR. SYNAPSE ·

Semaglutide, bahan aktif ing Ozempic lan Wegovy, nambah umur tikus betina tuwa ing riset anyar ing *Nature* saka UC Berkeley. Perawatan diwiwiti nalika umur 20 sasi lan niru akèh manfaat saka pembatasan kalori. Dibandhingake langsung, obat iki uga nuduhaké asil sing luwih apik tinimbang pembatasan kalori ing babagan motivasi eksplorasi, memori spasial, lan kontrol glukosa. Nanging iki mung riset tikus betina, tanpa pandhuan dosis kanggo manungsa.

Approach: the human outcome. Palette: natural.

A close, slightly low-angle shot of an elderly person's weathered hands resting on a wooden kitchen table beside a tall glass of creamy shake, a steel spoon and a small bowl of white creatine powder. Their forearm is relaxed, with visible tendons, age spots and loose skin, and the fingers are curled lightly as if gripping would take effort. Soft morning daylight comes through a window on the left, giving warm skin tones, a honey-colored oak table and blurred green houseplant leaves in the background. A thin ribbon of electric green from a straw or a cloth napkin gives a single small accent. The shallow depth of field keeps the face out of frame. The mood is quiet, dignified and hopeful but restrained, with no gym, no dumbbells and no text.
longevity

Suplemén Creatine-Leucine-MCT Nambah Otot ing Wong 77 Taun, Ora Nambah Kekuatan

BY DR. SYNAPSE ·

Sawijining uji coba acak kanthi 73 wong sarcopenik kanthi rata‑rata umur 77 taun nemokake yen suplemen wolung minggu sing adhedhasar creatine, protein tinggi leucine, lan MCT nambah massa otot appendikular nganti 0,42 kg (+3,2 %) sanajan ora ana latihan. Penambahan iki signifikan sacara statistik dibandhingake plasebo, nanging isih ngisor ambang klinis sing penting. Kekuatan genggaman tangan ora beda antarane klompok, sanajan peserta plasebo ngalami penurunan kira‑kira 7 %. Formula kasebut uga ngemot whey, resveratrol, lan vitamin D3, dadi ora siji bahan wae sing tanggung jawab. Kanggo wong tuwa sing ora bisa nglatih, iki katon minangka tambahan sing aman, nanging ora bisa nggenteni latihan resistensi.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Apa Ozempic lan Mounjaro Nggawa Depresi? Temuan saka 20 Studi

BY DR. SYNAPSE ·

Apa Ozempic lan Mounjaro bisa nambah risiko depresi utawa pikiran bunuh diri? Saka tinjauan sistematis 20 studi lan penilaian regulator EMA lan FDA, bukti paling kuat ora nuduhake risiko kasebut. Meta-analisis gedhe 2025 ora nemokake kenaikan suicidality, depresi, utawa kecemasan karo semaglutide utawa tirzepatide. Sinyal sing muncul luwih akeh amarga desain studi sing ora bisa misahake efek obat saka stres obesitas, risiko psikiatrik dhasar, lan bias pelaporan. Amarga uji coba asring ngilangi pasien psikiatrik, pengawasan tetep penting kanggo kelompok risiko dhuwur lan kanggo nglacak efek jangka panjang sing arang kelakon.

This page is available in